内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Bair Teresa Brophy. Director active across 1 company, notably Kura Oncology, Inc.. In total, 14 disclosures have been recorded. Split: 0 buy · 8 sells. Total volume traded: €553k. Activity tracked since 17 November 2022. The latest transaction was filed on 19 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Bair Teresa Brophy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
31,487 股@ US$12.63Common StockSEC:0001193125-26-361184:0
4,096 股@ US$8.460713.9% 占其流量Common StockSEC:0001193125-26-025301:0
50,000 股0Common StockSEC:0001193125-26-004562:0
48,900 股0Common StockSEC:0001193125-25-283568:0
48,900 股0Common StockSEC:0001193125-25-223666:0
1,559 股@ US$5.964.6% 占其流量Common StockSEC:0000950170-25-074660:0
2,437 股@ US$7.871910.2% 占其流量Common StockSEC:0000950170-25-010120:0
4,844 股@ US$7.871920.2% 占其流量Common StockSEC:0000950170-25-010120:1
46,250 股0Common StockSEC:0000950170-25-002062:0
2,615 股@ US$22.147729.5% 占其流量Common StockSEC:0000950170-24-062585:0
2,053 股@ US$17.800518.6% 占其流量Common StockSEC:0000950170-24-009495:0
46,250 股0Common StockSEC:0000950170-24-001847:0
23,125 股0Common StockSEC:0001209191-23-011287:0
2,100 股@ US$15.221217.0% 占其流量Common StockSEC:0001209191-22-057874:0
About Bair Teresa Brophy
Bair Teresa Brophy is a declarant linked to Kura Oncology, Inc., where she is Chief Legal Officer. Across 13 total filings, the 13 sampled filings cover the period from 2022-11-18 to 2026-01-27 and show EUR 0 in buys and EUR 210101 in sells, with the modal transaction nature listed as Cession.